QA: Catalent Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2021_Catalent_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 2.89334548769371, 'aggregate_val': 4271000000, 'exp_sum': 1097000000, 'exp_to_value': {'LiabilitiesCurrent': 893000000, 'LiabilitiesNoncurrent': 204000000, 'remainder_Liabilities': 0}}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 2.528811086797958, 'aggregate_val': 4838000000, 'exp_sum': 1371000000, 'exp_to_value': {'LiabilitiesCurrent': 1196000000, 'LiabilitiesNoncurrent': 175000000, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001596783, Catalent Inc

  xvar xval
0 AssetsCurrent 2,293,000,000
1 IntangibleAssetsNetIncludingGoodwill 3,360,000,000
2 PropertyPlantAndEquipmentNet 1,901,000,000
3 remainder_Assets 223,000,000
4 LiabilitiesCurrent 893,000,000
5 LiabilitiesNoncurrent 204,000,000
6 remainder_Liabilities 3,174,000,000
7 CostOfGoodsAndServicesSold 2,231,456,450
8 SellingGeneralAndAdministrativeExpense 581,318,557
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 49,233,470
11 remainder_Revenues 3,128,389,755
12 remainder_NetIncome -132,610,154
13 remainder_ComprehensiveNetIncome -30,937,671
  yvar yval
0 Assets 7,777,000,000
1 Liabilities 4,271,000,000
2 Expenses 2,862,008,477
3 Revenues 3,128,389,755
4 StockholdersEquity 3,506,000,000
5 NetIncome 133,771,124
6 ComprehensiveNetIncome 118,302,288
7 BaseVar 9,100,973,028
8 EconomicCapitalRatiobeforeLimitedLiability 1.29
9 EconomicCapitalRatio 2.52

Edgar->Model Mapping

Feature Distribution

Change over Time